Skip to content
Medical Health Aged Care

Dementia Australia honours the life and legacy of Patron Allan Moffat OBE

Dementia Australia 2 mins read

Dementia Australia honours iconic Australian motorsport figure and Dementia Australia Patron Allan Moffat OBE following his passing, aged 86. 

In 2019, Allan chose to speak publicly about his diagnosis of Alzheimer’s disease, sharing his experience to help others know they are not alone and to raise awareness and funds across the racing community and beyond. His honesty, determination and generosity inspired many and strengthened understanding of dementia in Australia. 

As Patron, Allan – together with his loyal support network – gave so much of himself to champion this cause. Since 2023, Dementia Australia has been honoured to be the nominated charity partner of the Penrite Oil Sandown 500 in Allan’s honour. The Supercars events have created powerful moments of connection trackside and helped raise vital awareness about dementia. 

Dementia Australia CEO Professor Tanya Buchanan acknowledged Allan’s extraordinary advocacy. 

“Allan was admired and respected not only as an icon of Australian motorsport, but also as an advocate who used his profile to make a meaningful difference for people of all ages living with dementia, their families and carers,” Professor Buchanan said. 

“Allan’s support of our work including Memory Walk & Jog events, fundraising initiatives, media stories and social media posts has made a difference in many ways to the lives of people impacted by dementia. His legacy of honesty, courage and generosity will continue to help families facing dementia for years to come.” 

Allan’s long-time manager Phil Grant reflects on Allan’s extraordinary role in championing dementia awareness. 

“Allan was so proud to be a Patron for Dementia Australia and in his honour, we encourage all his fans to donate in his name through the Allan Moffat Foundation to continue his legacy,” Mr Grant said.  

Dementia Australia extends its deepest sympathies to Allan’s family, friends and loyal supporters. We acknowledge the steadfast friendship and careful stewardship of Phil Grant, and the support of Allan’s son, Andrew, in enabling the Allan Moffat Foundation to continue this important work.  

  -Ends- 

Dementia Australia is the source of trusted information, education and services for the estimated more than 433,300 Australians living with dementia, and the more than 1.7 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you. 

For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au  

Media contacts: Catherine McCarthy, Media and Communications Advisor [email protected] 0466 796 201 

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines

Note to Editors: 

We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:  

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.  

Media

More from this category

  • Medical Health Aged Care, Political
  • 16/01/2026
  • 06:00
Monash University

National genomic screening program would save thousands of Australians from preventable cancer and heart disease

Leadinggenomic health experts from Monash University are calling for urgent government funding to progress the development of a national preventive genomic testing program that would save thousands of Australians from conditions like cancer and heart disease. This call to action follows a Monash-led nationwide pilot study recently completed, offering free genomic screening to 10,000 Australians aged 18 to 40. The pilot tested for 10 medically actionable genes linked to hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolaemia. The findings are published today in the inaugural edition of the new academic journal Nature Health. The pilot study was led…

  • Medical Health Aged Care
  • 16/01/2026
  • 00:11
QPS Holdings, LLC

QPS Selects Oracle Argus Safety Database to Enhance Pharmacovigilance in Clinical Trials

NEWARK, Del.–BUSINESS WIRE– QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials announces the successful implementation of…

  • Contains:
  • Medical Health Aged Care
  • 15/01/2026
  • 23:11
WHOOP

WHOOP and Samuel Ross MBE Announce Multiyear, Global Creative Partnership, Introducing a New Era in Performance Fashion

The WHOOP x SR_A collaboration ushers in a new frontier of performance accessories, apparel, and design-driven technology BOSTON–BUSINESS WIRE– WHOOP, the human performance company,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.